Emergent BioSolutions(美國)

Emergent BioSolutions

美國EmergentBioSolutionswww.emergentbiosolutions.comEmergentBioSolutions公司是一家生物制藥企業(yè)，致力于免疫相關生物產(chǎn)品的開發(fā)、生產(chǎn)和商業(yè)化，其產(chǎn)品包括疫苗和療法，能幫助人體免疫系統(tǒng)預防或治療疾病。Emergent的上市產(chǎn)品BioThrax®（炭疽吸附疫苗）是美國食品藥品管理局（FDA）認可的預防炭疽感染的疫苗。Emerge nt公司準備啟動和已經(jīng)啟動的開發(fā)項目中還有側重于炭疽、肉毒中毒、傷寒、結核、乙肝和衣原體的一些計劃。EmergentBioSolutionsInc.isaleadingbiopharmaceuticalcompanydedicatedtoonesimplemission—toprotectlife.Wedevelop,manufactureandcommercializeimmunerelatedbiologics,vaccinesandbiotherapeuticsthatassistthebody’simmunesystemtopreventortreatinfectiousandotherlifethreateningdiseases.Ourmarketedproduct,BioThrax®(AnthraxVaccineAdsorbed),istheonlyvaccinelicensedbytheU.S.FoodandDrugAdministrationforthepreventionofanthraxinfection.Ourproductpipelinealsoincludes:two“nextgeneration”anthraxvaccines,twoanthraxtherapeutics(immunoglobulinandmonoclonal),twobotulinumvaccinesandabotulinumtherapeutic,anoraltyphoi